Yiguang Lin
- Molecular Biology top 10%
- Oncology top 10%
- Epidemiology
- Cancer Research top 10%
- Immunology
- Co-authors
- Eileen McGowanNajah T. NassifNahal HaddadiAnn M. SimpsonSize ChenXianqin QuKaneez Fatima ShadLal S
- Topics
- CAR-T cell therapy research (9 papers)Glioma Diagnosis and Treatment (5 papers)Sphingolipid Metabolism and Signaling (5 papers)
- Journals
- Journal of the American Chemical SocietyAngewandte Chemie International EditionJournal of Clinical Oncology
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Yiguang Lin
89 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 857
- Oncology 304
- Epidemiology 204
- Cancer Research 204
- Immunology 184
Countries citing papers authored by Yiguang Lin
This map shows the geographic impact of Yiguang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiguang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiguang Lin more than expected).
Fields of papers citing papers by Yiguang Lin
This network shows the impact of papers produced by Yiguang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiguang Lin. The network helps show where Yiguang Lin may publish in the future.
Co-authorship network of co-authors of Yiguang Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Yiguang Lin. A scholar is included among the top collaborators of Yiguang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiguang Lin. Yiguang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 8 | |
| 6 | 10 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 0 | |
| 11 | 5 | |
| 12 | 26 | |
| 13 | 17 | |
| 14 | 15 | |
| 15 | 18 | |
| 16 | 3 | |
| 17 | 1 | |
| 18 | 79 | |
| 19 | 11 | |
| 20 | 14 |
About Yiguang Lin
Yiguang Lin is a scholar working on Oncology, Cancer Research and Toxicology, having authored 100 papers that have together received 1.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Glioma Diagnosis and Treatment (5 papers) and Sphingolipid Metabolism and Signaling (5 papers). The work is most often cited by research in Biotechnology (118 citations), Cancer Research (204 citations) and Molecular Biology (857 citations). Yiguang Lin has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Eileen McGowan, Najah T. Nassif, Nahal Haddadi, Ann M. Simpson, Size Chen, Xianqin Qu, Kaneez Fatima Shad, Lal S, Hongjie Chen and Laurence E. Mather. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.